|
ACTR3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.097950E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.543820E-02 |
| Normal-vs-Stage2 |
5.857600E-02 |
| Normal-vs-Stage3 |
3.626200E-02 |
| Normal-vs-Stage4 |
5.122800E-03 |
| Stage1-vs-Stage2 |
5.459000E-01 |
| Stage1-vs-Stage3 |
7.041600E-01 |
| Stage1-vs-Stage4 |
1.541550E-01 |
| Stage2-vs-Stage3 |
7.526400E-01 |
| Stage2-vs-Stage4 |
6.698800E-01 |
| Stage3-vs-Stage4 |
3.696800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.236500E-03 |
| Normal-vs-AfricanAmerican |
5.684600E-01 |
| Normal-vs-Asian |
6.746300E-02 |
| Caucasian-vs-AfricanAmerican |
8.03270000000467E-05 |
| Caucasian-vs-Asian |
4.832400E-01 |
| AfricanAmerican-vs-Asian |
1.633830E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.682420E-02 |
| Normal-vs-Female |
1.262050E-02 |
| Male-vs-Female |
9.723400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.705590E-01 |
| Normal-vs-Age(41-60Yrs) |
9.818400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.702060E-02 |
| Normal-vs-Age(81-100Yrs) |
7.685600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.630400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.459800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.704800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.181400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.911230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.363600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.492600E-01 |
| Normal-vs-Grade 2 |
1.859820E-02 |
| Normal-vs-Grade 3 |
1.172040E-02 |
| Normal-vs-Grade 4 |
1.946290E-02 |
| Grade 1-vs-Grade 2 |
7.974400E-01 |
| Grade 1-vs-Grade 3 |
9.971000E-01 |
| Grade 1-vs-Grade 4 |
5.336800E-01 |
| Grade 2-vs-Grade 3 |
6.175600E-01 |
| Grade 2-vs-Grade 4 |
5.447800E-01 |
| Grade 3-vs-Grade 4 |
3.850000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.004920E-03 |
| Normal-vs-ccB subtype |
9.559800E-03 |
| ccA subtype-vs-ccB subtype |
6.069000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.342600E-03 |
| Normal-vs-N1 |
5.431700E-02 |
| N0-vs-N1 |
2.495000E-01 |
|
|
